JPM European Media Internet 2019 Outlook_watermark
.pdfvk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Pearson: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
4,552 |
4,513 |
4,303 |
4,378 |
4,424 |
|
Cash flow from operating activities |
556 |
675 |
561 |
678 |
736 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
150 |
162 |
178 |
192 |
205 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
82 |
163 |
0 |
(15) |
(15) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
785 |
738 |
736 |
832 |
925 |
|
Cash flow from investing activities |
(185) |
189 |
(204) |
(278) |
(230) |
D&A |
(150) |
(162) |
(178) |
(192) |
(205) |
|
o/w Capital expenditure |
(247) |
(235) |
(224) |
(228) |
(230) |
Adj. EBIT |
635 |
576 |
558 |
639 |
720 |
|
as % of sales |
5.4% |
5.2% |
5.2% |
5.2% |
5.2% |
Net Interest |
(59) |
(79) |
(30) |
(38) |
(37) |
|
|
|
|
|
|
|
Adj. PBT |
576 |
497 |
528 |
602 |
683 |
|
Cash flow from financing activities |
(618) |
(1,658) |
(345) |
(223) |
(189) |
Tax |
(95) |
(55) |
32 |
(126) |
(143) |
|
o/w Dividends paid |
(424) |
(318) |
(132) |
(223) |
(189) |
Minority Interest |
(2) |
(2) |
(2) |
(2) |
(2) |
|
o/w Shares issued/(repurchased) |
(20) |
(149) |
(150) |
0 |
0 |
Adj. Net Income |
479 |
440 |
557 |
473 |
537 |
|
o/w Net debt issued/(repaid) |
(251) |
(1,297) |
0 |
0 |
0 |
Reported EPS |
58.84 |
54.06 |
71.44 |
60.74 |
68.97 |
|
Net change in cash |
(247) |
(794) |
11 |
178 |
316 |
Adj. EPS |
58.84 |
54.06 |
71.44 |
60.74 |
68.97 |
|
|
421 |
287 |
287 |
430 |
543 |
DPS |
52.00 |
17.00 |
28.58 |
24.29 |
27.59 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
107.4% |
(31.8%) |
(0.1%) |
50.2% |
26.3% |
||||||
Payout ratio |
88.4% |
31.4% |
40.0% |
40.0% |
40.0% |
|
|
|
|
|
|
|
Shares outstanding |
814 |
814 |
780 |
779 |
779 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
1,424 |
630 |
641 |
819 |
1,135 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
|
- |
|
EBITDA margin |
17.2% |
16.4% |
17.1% |
19.0% |
20.9% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
13.9% |
12.8% |
13.0% |
14.6% |
16.3% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
10.5% |
9.7% |
13.0% |
10.8% |
12.1% |
Current assets |
1,424 |
630 |
641 |
819 |
1,135 |
|
Organic Revenue growth |
(7.7%) |
(2.0%) |
(0.2%) |
0.7% |
1.0% |
PP&E |
8,642 |
7,258 |
7,204 |
7,255 |
7,295 |
|
Net debt/EBITDA |
1.4 |
0.6 |
0.6 |
0.3 |
(0.1) |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.4 |
0.5 |
0.5 |
0.6 |
0.5 |
Total assets |
10,066 |
7,888 |
7,845 |
8,074 |
8,431 |
|
Assets/Equity (x) |
2.0 |
2.1 |
1.9 |
1.9 |
1.8 |
|
|
|
|
|
|
|
Interest cover (x) |
13 3 |
9.3 |
24.5 |
22.0 |
25.0 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
- |
|
Tax rate |
16.5% |
11.1% |
6.0% |
21.0% |
21.0% |
Payables |
3,202 |
2,814 |
2,584 |
2,700 |
2,716 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
1.9% |
(0 9%) |
(4.7%) |
1.8% |
1.0% |
Current liabilities |
3,202 |
2,814 |
2,584 |
2,700 |
2,716 |
|
EBITDA y/y Growth |
(10.0%) |
(6.0%) |
(0.3%) |
13.1% |
11.2% |
Long-term debt |
2,516 |
1,053 |
1,053 |
1,053 |
1,053 |
|
EPS y/y Growth |
(16.3%) |
(8.1%) |
32.1% |
(15.0%) |
13.6% |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
5,718 |
3,867 |
3,637 |
3,753 |
3,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
4,344 |
4,013 |
4,198 |
4,308 |
4,646 |
|
P/E (x) |
15 5 |
16.9 |
12.8 |
15.0 |
13.2 |
Minority interests |
4 |
8 |
10 |
12 |
15 |
|
FCFE Yield |
4.7% |
3.1% |
3.6% |
5.6% |
7.1% |
Total liabilities & equity |
10,066 |
7,888 |
7,845 |
8,074 |
8,431 |
|
EV/EBITDA (x) |
11.0 |
10.8 |
10.4 |
9.0 |
7.7 |
|
|
|
|
|
|
|
Dividend Yield |
5.7% |
1 9% |
3.1% |
2.7% |
3.0% |
Net debt/(cash) |
1,092 |
423 |
412 |
234 |
(82) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: £ in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
61
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Overweight
Company Data
Price (€) |
16.75 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
30.00 |
Price Target End Date |
30-Sep-19 |
52-week Range (€) |
33.04-16.45 |
Market Cap (€ bn) |
3.83 |
Shares O/S (mn) |
229 |
Pro7 DCF (€m)
WACC |
9.8% |
G |
2.5% |
NPV 2018-30 |
4,837 |
Terminal value |
4,469 |
EV |
9,306 |
Less Net Debt |
-2,099 |
Add Assoc / Stakes |
100 |
Less minorities |
-528 |
Equity |
6,778 |
Equity value / share (€) |
30.0 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
ProSiebenSat.1
ProSiebenSat.1 (PSMGn.DE;PSM GR)
FYE Dec |
2017A |
2018E |
2018E |
2019E |
2019E |
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Adj. EPS FY (€) |
2.40 |
2.38 |
2.34 |
2.07 |
1.97 |
Revenue FY (€ mn) |
4,078 |
3,999 |
3,991 |
4,157 |
4,151 |
Adj EBITDA FY (€ mn) |
1,050 |
1,027 |
1,015 |
974 |
949 |
EBITDA Margin FY |
25.8% |
25.7% |
25.4% |
23.4% |
22.9% |
Adjusted EBIT FY (€ mn) |
871 |
869 |
855 |
814 |
781 |
Adjusted Diluted NP FY (€ |
550 |
549 |
536 |
478 |
445 |
mn) |
|
|
|
|
|
Net debt / (cash) FY (€ mn) |
1,632 |
1,581 |
2,099 |
1,557 |
2,057 |
DPS (Net) FY (€) |
1.93 |
1.91 |
1.17 |
1.03 |
0.98 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks ProSiebenSat.1 (Overweight; Price Target: €30.00)
Investment Thesis
The significant de-rating over the past year creates, in our view, an exceptional opportunity to buy into the fastest-growing, most innovative and diversified broadcaster at what we consider a compelling valuation. Pro7 is more than just a broadcaster. It is using its existing programming spend and ad inventory to drive multiple revenue streams from distribution, digital entertainment, content and commerce. We believe it can return to mid-single-digit organic growth and that either buybacks, or preferably M&A, can help drive double-digit EPS growth.
Valuation
We decrease our PT from €40 to €30 as we increase our WACC from 8.5% to 9.8% to reflect the lower attractiveness of broadcasters in the current macro cycle. Pro7 trades on 7.8x headline 2019E earnings and offers a dividend yield of 6% at current levels. On an ex-dividend basis, it will trade on just 7.2x earnings.
Risks to Rating and Price Target
The following risks could prevent the stock from achieving our target price and rating: 1) A more rapid-than-expected deterioration of the economic and advertising environment in Germany in 2018 / 2019; and 2) lower-than-expected growth in revenues and profits from diversification.
62
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
ProSiebenSat.1: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
3,799 |
4,078 |
3,991 |
4,151 |
4,330 |
|
Cash flow from operating activities |
589 |
565 |
824 |
469 |
568 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
206 |
263 |
205 |
212 |
218 |
Gross profit |
|
|
- |
- |
- |
|
o/w Changes in working capital |
(14) |
(88) |
0 |
(15) |
(15) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
1,017 |
1,050 |
1,015 |
949 |
1,041 |
|
Cash flow from investing activities |
(489) |
309 |
(364) |
(40) |
(35) |
D&A |
(206) |
(263) |
(205) |
(212) |
(218) |
|
o/w Capital expenditure |
|
|
|
|
|
Adj. EBIT |
867 |
871 |
855 |
781 |
867 |
|
as % of sales |
- |
- |
- |
- |
- |
Net Interest |
(84) |
(83) |
(86) |
(84) |
(81) |
|
|
|
|
|
|
|
Adj. PBT |
748 |
778 |
764 |
663 |
751 |
|
Cash flow from financing activities |
619 |
(472) |
(496) |
(268) |
(226) |
Tax |
(206) |
(165) |
(212) |
(201) |
(227) |
|
o/w Dividends paid |
(406) |
(449) |
(446) |
(268) |
(226) |
Minority Interest |
(8) |
(10) |
(16) |
(18) |
(23) |
|
o/w Shares issued/(repurchased) |
515 |
0 |
(50) |
0 |
0 |
Adj. Net Income |
536 |
550 |
536 |
445 |
501 |
|
o/w Net debt issued/(repaid) |
510 |
(23) |
0 |
0 |
0 |
Reported EPS |
1.96 |
2.06 |
0.18 |
1 55 |
1.89 |
|
Net change in cash |
719 |
402 |
(36) |
161 |
307 |
Adj. EPS |
2.37 |
2.40 |
2.34 |
1.97 |
2.22 |
|
|
589 |
565 |
824 |
469 |
568 |
DPS |
1.90 |
1.93 |
1.17 |
0.98 |
1.11 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
(10.9%) |
(4.0%) |
45.8% |
(43.1%) |
21.2% |
||||||
Payout ratio |
97.0% |
93.7% |
658.8% |
63.4% |
58.7% |
|
|
|
|
|
|
|
Shares outstanding |
226 |
229 |
229 |
226 |
226 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
1,271 |
1,552 |
1,085 |
1,127 |
1,319 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
1,958 |
1,915 |
2,205 |
2,170 |
2,155 |
|
EBITDA margin |
26.8% |
25.8% |
25.4% |
22 9% |
24.0% |
Inventories |
|
|
|
|
|
|
EBIT margin |
20.4% |
20.1% |
17.5% |
16.6% |
18.3% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
14.1% |
13.5% |
13.4% |
10.7% |
11.6% |
Current assets |
3,229 |
3,467 |
3,290 |
3,297 |
3,474 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
3,374 |
3,102 |
3,424 |
3,420 |
3,412 |
|
Net debt/EBITDA |
188.2% |
155.4% |
206.8% |
216.7% |
179.2% |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.6 |
0.6 |
0.6 |
0.6 |
0.6 |
Total assets |
6,603 |
6,569 |
6,714 |
6,717 |
6,885 |
|
Assets/Equity (x) |
5.0 |
4.9 |
5.6 |
5.9 |
5.4 |
|
|
|
|
|
|
|
Interest cover (x) |
12.1 |
12.7 |
11.8 |
11.3 |
12.8 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
|
|
Tax rate |
27.5% |
21.2% |
27.8% |
30 3% |
30.2% |
Payables |
|
|
|
|
- |
|
|
|
|
|
|
|
Other short term liabilities |
1,986 |
2,133 |
2,423 |
2,373 |
2,343 |
|
Revenue y/y Growth |
16.5% |
7.3% |
(2.1%) |
4.0% |
4.3% |
Current liabilities |
1,986 |
2,133 |
2,423 |
2,373 |
2,343 |
|
EBITDA y/y Growth |
9.8% |
3.3% |
(3.3%) |
(6 5%) |
9.7% |
Long-term debt |
3,185 |
3,184 |
3,184 |
3,184 |
3,184 |
|
EPS y/y Growth |
9.6% |
1.4% |
(2.5%) |
(16.1%) |
12.7% |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
5,171 |
5,317 |
5,607 |
5,557 |
5,527 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
1,432 |
1,252 |
1,107 |
1,160 |
1,358 |
|
P/E (x) |
7.1 |
7.0 |
7.1 |
8.5 |
7.6 |
Minority interests |
|
|
|
|
|
|
FCFE Yield |
13.3% |
12.6% |
10.3% |
9 3% |
11.9% |
Total liabilities & equity |
6,603 |
6,569 |
6,714 |
6,717 |
6,885 |
|
EV/EBITDA (x) |
5.8 |
5.3 |
5 9 |
6.3 |
5.6 |
|
|
|
|
|
|
|
Dividend Yield |
11.3% |
11.5% |
7.0% |
5 9% |
6.6% |
Net debt/(cash) |
1,914 |
1,632 |
2,099 |
2,057 |
1,865 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
63
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Overweight
Company Data
Price (€) |
48.45 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
68.00 |
Price Target End Date |
31-Dec-19 |
52-week Range (€) |
63.18-47.79 |
Market Cap (€ mn) |
11,162.14 |
Shares O/S (mn) |
230 |
Publicis Groupe
Publicis Groupe (PUBP.PA;PUB FP)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
4.36 |
4.20 |
4.42 |
4.39 |
Adj P/E FY |
11.1 |
11.5 |
11.0 |
11.0 |
Revenue FY (€ mn) |
9,690 |
9,382 |
9,676 |
9,610 |
Adj.EBITA FY (€ mn) |
1,505 |
1,479 |
1,562 |
1,551 |
Adj.EBITA Margin FY |
15.5% |
15.8% |
16.1% |
16.1% |
DPS (Net) FY (€) |
2.00 |
2.10 |
2.21 |
2.19 |
Net Income adjusted FY (€ |
1,005 |
973 |
1,029 |
1,021 |
mn) |
|
|
|
|
Dividend Yield FY |
4.1% |
4.3% |
4.6% |
4.5% |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks Publicis Groupe (Overweight; Price Target: €68.00)
Investment Thesis
The ad agency sub sector has seen a major derating over the last two years driven by concerns around disintermediation and increased competitive pressure from consultancies. We see value at this stage - the share price factors in flat growth for the next two years which we consider as too harsh. The shares trading on 10.6x 2019 P/E offers risk to the upside.
Valuation
We value all Agencies on a DCF basis. Our Dec 2019 target price based on a WACC of 8% and terminal growth rate of 2% is €68 (from €76).
Publicis: J.P. Morgan DCF analysis
€ million, as at 31 Dec 18E
Present Value of FCF (20-27) (€m) |
6,032 |
Present value of Terminal Value (€m) |
9,787 |
Total Enterprise Value (€m) |
15,819 |
Net (Debt)/cash FY19 (€m) - including earn-out |
373 |
Pension deficit |
(333) |
Associates |
-70 |
Minorities |
0 |
Equity Value (€m) |
15,789 |
Fully diluted Shares (m) |
232.7 |
Publicis Equity Value per Share (€) |
67.9 |
Discount applied to fair value |
0.0% |
DCF Target price (€) |
68 |
Source: J P. Morgan estimates
Risks to Rating and Price Target
The following risks could prevent the stock from achieving our target price and rating: 1) worse-than-expected economic and advertising environment (particularly following Brexit); 2) disruption to the underlying business as a result of management distraction from structure change; 3) value-destroying acquisitions; 4) difficulties integrating Sapient, lower-than-expected cost synergies, and lower-than-expected underlying growth performance from Sapient; 5) significant loss of media/creative accounts; and 6) Increased competition from IT/Consultancy firms.
64
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Publicis Groupe: Summary of Financials
Income Statement |
FY16A FY17A FY18E FY19E FY20E |
||||
Revenue |
9,733 |
9,690 |
9,382 |
9,610 |
9,770 |
COGS |
- |
- |
- |
- |
- |
Gross profit |
- |
- |
- |
- |
- |
SG&A |
- |
- |
- |
- |
- |
Adj. EBITDA |
1,682 |
1,666 |
1,639 |
1,709 |
1,690 |
D&A |
(166) |
(161) |
(159) |
(159) |
(156) |
Adj. EBIT |
1,516 |
1,505 |
1,479 |
1,551 |
1,534 |
Net Interest |
(182) |
(127) |
(127) |
(131) |
(116) |
Cash Flow Statement |
|
FY16A FY17A FY18E FY19E FY20E |
||||
Cash flow from operating activities |
1,072 |
1,487 |
1,351 |
1,399 |
1,408 |
|
o/w Depreciation & amortization |
166 |
161 |
159 |
159 |
156 |
|
o/w Changes in working capital |
|
(355) |
69 |
0 |
0 |
0 |
|
(411) |
(417) |
(139) |
(159) |
(156) |
|
Cash flow from investing activities |
||||||
o/w Capital expenditure |
(173) |
(136) |
(139) |
(159) |
(156) |
|
as % of sales |
1.8% |
1.4% |
1.5% |
1.7% |
1.6% |
|
|
|
|
|
|
|
|
Adj. PBT |
1,334 |
1,378 |
1,352 |
1,420 |
1,418 |
|
Cash flow from financing activities |
(237) |
(514) |
(505) |
(532) |
(558) |
|
Tax |
(415) |
(358) |
(365) |
(383) |
(369) |
|
o/w Dividends paid |
(213) |
(180) |
(462) |
(489) |
(515) |
|
Minority Interest |
(7) |
(10) |
(10) |
(10) |
(10) |
|
o/w Shares issued/(repurchased) |
- |
(291) |
0 |
0 |
0 |
|
Adj. Net Income |
1,015 |
1,005 |
973 |
1,021 |
1,034 |
|
o/w Net debt issued/(repaid) |
20 |
(8) |
(8) |
(8) |
(8) |
|
Reported EPS |
4.46 |
4 36 |
4 20 |
4.39 |
4.42 |
|
Net change in cash |
|
550 |
177 |
707 |
708 |
693 |
Adj. EPS |
4.46 |
4.36 |
4.20 |
4.39 |
4.42 |
|
|
1,024 |
1,445 |
1,305 |
1,336 |
1,337 |
|
DPS |
1.85 |
2.00 |
2.10 |
2.19 |
2.21 |
|
Adj. Free cash flow to firm |
||||||
|
y/y Growth |
(17.2%) |
41.1% |
(9.7%) |
2.4% |
0.1% |
|||||||
Payout ratio |
41.5% |
45 9% |
50.0% |
50.0% |
50.0% |
|
|
|
|
|
|
|
|
Shares outstanding |
228 |
231 |
232 |
233 |
234 |
|
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
|
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
2,228 |
2,407 |
2,855 |
3,284 |
3,683 |
|
Gross margin |
- |
- |
- |
- |
- |
|
Accounts receivable |
10,010 |
9,750 |
9,750 |
9,750 |
9,750 |
|
EBITDA margin |
17.3% |
17.2% |
17 5% |
17.8% |
17.3% |
|
Inventories |
406 |
385 |
385 |
385 |
385 |
|
EBIT margin |
15.6% |
15.5% |
15.8% |
16.1% |
15.7% |
|
Other current assets |
698 |
711 |
649 |
649 |
649 |
|
Net profit margin |
10.4% |
10.4% |
10.4% |
10.6% |
10.6% |
|
Current assets |
13,342 |
13,253 |
13,639 |
14,068 |
14,467 |
|
Organic Revenue growth |
0.7% |
0.8% |
0.8% |
1 5% |
1.6% |
|
PP&E |
640 |
590 |
510 |
447 |
383 |
|
Net debt/EBITDA |
0.7 |
0.6 |
0.2 |
(0.2) |
(0.6) |
|
LT investments |
419 |
363 |
363 |
363 |
363 |
|
|
|
|
|
|
|
|
Other non current assets |
10,495 |
9,574 |
9,380 |
9,163 |
8,970 |
|
Sales/Assets (x) |
0.4 |
0.4 |
0.4 |
0.4 |
0.4 |
|
Total assets |
24,896 |
23,780 |
23,892 |
24,041 |
24,182 |
|
Assets/Equity (x) |
4.0 |
4.1 |
3.8 |
3.6 |
3.4 |
|
|
|
|
|
|
|
|
Interest cover (x) |
9 2 |
13.1 |
12.9 |
13.1 |
14.6 |
|
|
|
|
|
|
|
|
|||||||
Short term borrowings |
283 |
350 |
350 |
350 |
350 |
|
Tax rate |
31.1% |
26.0% |
27.0% |
27.0% |
26.0% |
|
Payables |
11,992 |
11,541 |
11,541 |
11,541 |
11,541 |
|
|
|
|
|
|
|
|
Other short term liabilities |
2,323 |
2,141 |
2,125 |
2,125 |
2,125 |
|
Revenue y/y Growth |
1.4% |
(0.4%) |
(3.2%) |
2.4% |
1.7% |
|
Current liabilities |
14,598 |
14,032 |
14,016 |
14,016 |
14,016 |
|
EBITDA y/y Growth |
1.3% |
(1.0%) |
(1.6%) |
4 3% |
(1.1%) |
|
Long-term debt |
3,028 |
2,780 |
2,426 |
2,072 |
1,726 |
|
EPS y/y Growth |
1.6% |
(2.3%) |
(3.6%) |
4 5% |
0.8% |
|
Other long term liabilities |
1,205 |
1,010 |
1,010 |
1,010 |
1,010 |
|
|
|
|
|
|
|
|
Total liabilities |
18,831 |
17,822 |
17,452 |
17,098 |
16,752 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
|
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
6,055 |
5,956 |
6,437 |
6,940 |
7,427 |
|
P/E (x) |
10 9 |
11.1 |
11.5 |
11.0 |
11.0 |
|
Minority interests |
10 |
2 |
2 |
3 |
4 |
|
FCFE Yield |
- |
- |
- |
- |
- |
|
Total liabilities & equity |
24,896 |
23,780 |
23,892 |
24,041 |
24,182 |
|
EV/EBITDA (x) |
1.0 |
0 9 |
0.4 |
0.0 |
NM |
|
|
|
|
|
|
|
|
Dividend Yield |
3.8% |
4.1% |
4.3% |
4 5% |
4.6% |
|
Net debt/(cash) |
1,244 |
1,059 |
343 |
(373) |
(1,074) |
|
|||||||
|
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data) Fiscal year ends Dec. o/w - out of which
65
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Overweight
Company Data
Price (p) |
1,610 |
Date Of Price |
07 Dec 18 |
Price Target (p) |
1,840 |
Price Target End Date |
31-Mar-19 |
52-week Range (p) |
1,751-1,399 |
Market Cap (£ bn) |
17.39 |
Shares O/S (mn) |
1,081 |
RELX Group: J.P.Morgan DCF analysis
£ million, as at 30 Jun 2019E
WACC |
7.8% |
Terminal growth |
2.2% |
NPV of cash flows to 2027E |
17,552 |
NPV of Terminal Value |
25,668 |
Implied Enterprise Value |
43,219 |
Net debt |
-5,585 |
Pensions |
-100 |
Value prop. Consol. |
-96 |
Implied Equity Value |
37,438 |
NOSH (m) - combined |
2035 |
Fair Value of PLC shares (p) |
1,840 |
Europe Equity Research
10 December 2018
RELX PLC
RELX PLC (REL.L;REL LN)
FYE Dec |
2017A |
2018E |
2018E |
2019E |
2019E |
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Adj. EPS FY (p) |
80.22 |
85.29 |
85.36 |
94.21 |
94.88 |
Revenue FY (£ mn) |
7,341 |
7,556 |
7,566 |
8,038 |
8,121 |
EBITDA FY (£ mn) |
2,556 |
2,648 |
2,650 |
2,838 |
2,857 |
EBITA (Calc) FY (£ mn) |
2,284 |
2,368 |
2,370 |
2,540 |
2,556 |
Operating margin FY |
31.1% |
31.3% |
31.3% |
31.6% |
31.5% |
Pretax Profit Adjusted FY |
2,101 |
2,170 |
2,172 |
2,342 |
2,359 |
(£ mn) |
|
|
|
|
|
Net Att. Income FY (£ mn) |
1,620 |
1,684 |
1,686 |
1,818 |
1,831 |
DPS (Gross) FY (p) |
39.40 |
42.64 |
42.68 |
47.10 |
47.44 |
Adj P/E FY |
20.1 |
18.9 |
18.9 |
17.1 |
17.0 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks
RELX PLC (Overweight; Price Target: 1,840p)
Investment Thesis
We maintain our Overweight rating. RELX offers structural growth supported by increasingly sophisticated information-based analytics and decision-making tools. We expect group organic revenue growth of c4%, EBIT growth of c6% and EPS growth c10% over 18E-21E supported by gradual margin expansion, bolt-on acquisitions and buybacks. RELX’s STM division offers strong cash generation and predictable revenues, which when combined with business and geographic diversification at the group level, results in the best earnings visibility / quality in the media sector. RELX offers a 3% yield and trades on c17.1x 2019E earnings, which is attractive vs staples and its US information peers (-15% discount).
Valuation
Our price target decreases from 1,880p to 1,840p as a result of slightly lower terminal growth (2.2% vs. 2.4%). Our DCF based valuation assumes medium-term organic revenue / EBITA growth of 4% / 5% growth and a WACC of 7.8%.
Risks to Rating and Price Target
1) The business proves less resilient than we expect with greater slowdown in cyclical revenues in parts of R&BA and Exhibitions; 2) Higher product investment higher; 3) FX moves; 4) Financial leverage is higher than expected, and / or cash returns lower than expected; 5) Any negative open access news flow and 6) Any market preference for cyclical stocks over defensives, or investor rotation away from perceived “bond proxy” stocks.
66
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
RELX PLC: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A FY17A FY18E FY19E FY20E |
||||
Revenue |
6,895 |
7,341 |
7,566 |
8,121 |
8,550 |
|
Cash flow from operating activities |
1,682 |
1,848 |
1,934 |
2,106 |
2,237 |
COGS |
|
|
|
|
- |
|
o/w Depreciation & amortization |
257 |
272 |
280 |
301 |
317 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
(72) |
(47) |
(42) |
(37) |
(37) |
SG&A |
|
|
|
|
- |
|
|
|
|
|
|
|
Adj. EBITDA |
2,371 |
2,556 |
2,650 |
2,857 |
3,019 |
|
Cash flow from investing activities |
(677) |
(432) |
(936) |
(563) |
(584) |
D&A |
(257) |
(272) |
(280) |
(301) |
(317) |
|
o/w Capital expenditure |
(332) |
(353) |
(364) |
(391) |
(411) |
Adj. EBIT |
2,114 |
2,284 |
2,370 |
2,556 |
2,702 |
|
as % of sales |
4.8% |
4.8% |
4.8% |
4.8% |
4.8% |
Net Interest |
(180) |
(183) |
(198) |
(197) |
(196) |
|
|
|
|
|
|
|
Adj. PBT |
1,934 |
2,101 |
2,172 |
2,359 |
2,506 |
|
Cash flow from financing activities |
(965) |
(1,467) |
(897) |
(1,551) |
(1,666) |
Tax |
(438) |
(473) |
(478) |
(519) |
(551) |
|
o/w Dividends paid |
(683) |
(762) |
(797) |
(851) |
(916) |
Minority Interest |
(8) |
(8) |
(8) |
(9) |
(9) |
|
o/w Shares issued/(repurchased) |
(700) |
(700) |
(700) |
(800) |
(950) |
Adj. Net Income |
1,488 |
1,620 |
1,686 |
1,831 |
1,946 |
|
o/w Net debt issued/(repaid) |
393 |
8 |
600 |
100 |
200 |
Reported EPS |
71 55 |
80 22 |
85 36 |
94.88 |
103.50 |
|
Net change in cash |
40 |
(51) |
101 |
(8) |
(14) |
Adj. EPS |
71.55 |
80.22 |
85.36 |
94.88 |
103.50 |
|
|
1,537 |
1,671 |
1,796 |
1,940 |
2,049 |
DPS |
35.95 |
39.40 |
42.68 |
47.44 |
51.75 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
19.9% |
8.7% |
7.5% |
8.0% |
5.6% |
||||||
Payout ratio |
50.2% |
49.1% |
50.0% |
50.0% |
50.0% |
|
|
|
|
|
|
|
Shares outstanding |
2,080 |
2,019 |
1,975 |
1,930 |
1,880 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
162 |
111 |
212 |
203 |
190 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
|
- |
|
EBITDA margin |
34.4% |
34.8% |
35.0% |
35.2% |
35.3% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
30.7% |
31.1% |
31.3% |
31.5% |
31.6% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
21.6% |
22.1% |
22.3% |
22.6% |
22.8% |
Current assets |
162 |
111 |
212 |
203 |
190 |
|
Organic Revenue growth |
4.3% |
4.1% |
4.1% |
3.9% |
4.0% |
PP&E |
|
|
|
|
- |
|
Net debt/EBITDA |
2.0 |
2.0 |
2.1 |
2.0 |
2.0 |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
13,161 |
12,172 |
12,859 |
13,148 |
13,441 |
|
Sales/Assets (x) |
0.6 |
0.6 |
0.6 |
0.6 |
0.6 |
Total assets |
13,323 |
12,283 |
13,071 |
13,351 |
13,631 |
|
Assets/Equity (x) |
5 5 |
5.5 |
5.1 |
4 9 |
4.7 |
|
|
|
|
|
|
|
Interest cover (x) |
13 2 |
14.0 |
13.4 |
14 5 |
15.4 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
- |
|
Tax rate |
22.6% |
22.5% |
22.0% |
22.0% |
22.0% |
Payables |
|
|
|
|
- |
|
|
|
|
|
|
|
Other short term liabilities |
- |
- |
- |
- |
- |
|
Revenue y/y Growth |
15.5% |
6 5% |
3.1% |
7.3% |
5.3% |
Current liabilities |
- |
- |
- |
- |
- |
|
EBITDA y/y Growth |
15.7% |
7.8% |
3.7% |
7.8% |
5.7% |
Long-term debt |
4,843 |
5,197 |
5,797 |
5,897 |
6,097 |
|
EPS y/y Growth |
19.4% |
12.1% |
6.4% |
11.2% |
9.1% |
Other long term liabilities |
6,122 |
4,712 |
4,675 |
4,638 |
4,601 |
|
|
|
|
|
|
|
Total liabilities |
10,965 |
9,909 |
10,472 |
10,535 |
10,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
2,320 |
2,353 |
2,580 |
2,800 |
2,919 |
|
P/E (x) |
22 5 |
20.1 |
18 9 |
17.0 |
15.6 |
Minority interests |
38 |
21 |
19 |
17 |
15 |
|
FCFE Yield |
4.1% |
4.7% |
5.0% |
5.6% |
6.1% |
Total liabilities & equity |
13,323 |
12,283 |
13,071 |
13,351 |
13,631 |
|
EV/EBITDA (x) |
9.0 |
8.4 |
7.8 |
7.1 |
- |
|
|
|
|
|
|
|
Dividend Yield |
2.2% |
2.4% |
2.7% |
2.9% |
3.2% |
Net debt/(cash) |
4,681 |
5,086 |
5,585 |
5,694 |
5,907 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: £ in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
67
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Neutral
Company Data
Price (€) |
49.36 |
Date Of Price |
07-Dec-18 |
Price Target (€) |
56.00 |
Price Target End Date |
30-Sep-19 |
52-week Range (€) |
72.90-48.58 |
Market Cap (€ mn) |
7,579.87 |
Shares O/S (mn) |
154 |
RTL DCF (€m)
WACC |
9.4% |
G |
1.5% |
NPV 2018-30 |
6,015 |
Terminal value |
4,544 |
EV |
10,559 |
Less Net Debt |
-560 |
Less minorities |
-1,433 |
Equity |
8,565 |
No Shares |
154 |
Equity value / share |
56 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
RTL
RTL Group (AUDKt.BR;RTL BB)
FYE Dec |
2017A |
2018E |
2018E |
2019E |
2019E |
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Adj.EPS FY (€) |
4.83 |
4.75 |
4.62 |
5.00 |
4.51 |
Revenue FY (€ mn) |
6,373 |
6,540 |
6,508 |
6,819 |
6,630 |
EBITDA FY (€ mn) |
1,464 |
1,407 |
1,364 |
1,466 |
1,338 |
EBITDA Margin FY |
23.0% |
21.5% |
21.0% |
21.5% |
20.2% |
EBIT FY (€ mn) |
1,248 |
1,178 |
1,162 |
1,229 |
1,124 |
EBIT Margin FY |
19.6% |
18.0% |
17.9% |
18.0% |
17.0% |
Net Profit FY (€ mn) |
741 |
730 |
710 |
768 |
692 |
DPS (Net) FY (€) |
4.00 |
4.75 |
3.84 |
5.00 |
4.51 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks RTL (Neutral; Price Target: €56.00)
Investment Thesis
We downgrade RTL from OW to Neutral. RTL has outperformed the peers by c7% over the past year. Improving operational momentum stalled in Q3 with a step down in German ad growth which has continued into Q4. We believe this partly reflects the relatively loss of audience share to Pro7 but also weakening macro momentum. It remains to be seen whether this will be short-lived but German ad growth is likely to remain lackluster in Q1 given the timing of Easter which, along with the absence of the World Cup, will benefit Q2.
We cut our 2019 EPS by 10% to reflect a cautious macro backdrop, weaker ad growth, €20m of incremental programming costs for international football and €35m of OTT / streaming investment (content, platforms, data and technology).
RTL trades on 11.0x 2019 NOPAT for 2% 3 year growth vs 10.8x and 4% for the peer group. We are also somewhat frustrated by the slow pace of strategic change – we would like to see a greater sense of urgency and RTL taking a leading role in national / pan-European co-operation & consolidation, and to invest from a position of strength to drive OTT, DTC / distribution fees, smart reach & data driven targeted advertising.
We have a preference for Pro7 which is building a new model for FTA, trades on a similar multiple but offers faster growth. MediaScreen – RTL ranks 26/32 in the slowdown given slow growth and poor earnings momentum. Should we move to contraction it moves up to 16/32 given the increased weighting of value vs growth.
Valuation
Our DCF-based PT decreases from €80 to €56 / share given our lower estimates.
Risks to Rating and Price Target
We see the following risks to our rating and price target: 1) higher/lower-than- expected advertising revenues in '18; and 2) an improvement or deterioration of production profitability.
68
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
RTL: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
6,237 |
6,373 |
6,508 |
6,630 |
6,809 |
|
Cash flow from operating activities |
1,107 |
1,035 |
960 |
1,005 |
1,029 |
COGS |
|
|
|
- |
- |
|
o/w Depreciation & amortization |
214 |
218 |
202 |
214 |
222 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
(83) |
(89) |
(30) |
(20) |
(20) |
SG&A |
|
|
|
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
1,411 |
1,464 |
1,364 |
1,338 |
1,351 |
|
Cash flow from investing activities |
(312) |
(269) |
(249) |
(253) |
(257) |
D&A |
(206) |
(216) |
(202) |
(214) |
(222) |
|
o/w Capital expenditure |
(257) |
(239) |
(249) |
(253) |
(257) |
Adj. EBIT |
1,205 |
1,248 |
1,162 |
1,124 |
1,129 |
|
as % of sales |
4.1% |
3.8% |
3.8% |
3.8% |
3.8% |
Net Interest |
(18) |
(24) |
(25) |
(25) |
(25) |
|
|
|
|
|
|
|
Adj. PBT |
1,187 |
1,224 |
1,137 |
1,099 |
1,104 |
|
Cash flow from financing activities |
(863) |
(957) |
(722) |
(721) |
(797) |
Tax |
(363) |
(385) |
(324) |
(313) |
(315) |
|
o/w Dividends paid |
(16) |
(148) |
(88) |
(80) |
(78) |
Minority Interest |
(96) |
(98) |
(103) |
(94) |
(92) |
|
o/w Shares issued/(repurchased) |
(1) |
1 |
0 |
0 |
0 |
Adj. Net Income |
728 |
741 |
710 |
692 |
698 |
|
o/w Net debt issued/(repaid) |
(108) |
(205) |
0 |
0 |
0 |
Reported EPS |
4.74 |
4.83 |
4.62 |
4 51 |
4.54 |
|
Net change in cash |
(68) |
(191) |
(10) |
31 |
(25) |
Adj. EPS |
4.74 |
4.83 |
4.62 |
4.51 |
4.54 |
|
|
845 |
775 |
623 |
671 |
694 |
DPS |
4.00 |
4.00 |
3.84 |
4.51 |
4.54 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
2.9% |
(8.3%) |
(19.7%) |
7.8% |
3.3% |
||||||
Payout ratio |
84.4% |
82.9% |
83.0% |
100.0% |
100.0% |
|
|
|
|
|
|
|
Shares outstanding |
154 |
154 |
154 |
154 |
154 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
433 |
265 |
255 |
286 |
261 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
- |
- |
|
EBITDA margin |
22.6% |
23.0% |
21.0% |
20.2% |
19.8% |
Inventories |
|
|
|
- |
- |
|
EBIT margin |
19.3% |
19.6% |
17 9% |
17.0% |
16.6% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
11.7% |
11.6% |
10 9% |
10.4% |
10.2% |
Current assets |
433 |
265 |
255 |
286 |
261 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
7,867 |
7,629 |
7,707 |
7,767 |
7,822 |
|
Net debt/EBITDA |
- |
- |
- |
- |
- |
LT investments |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.8 |
0.8 |
0.8 |
0.8 |
0.8 |
Total assets |
8,300 |
7,894 |
7,962 |
8,053 |
8,083 |
|
Assets/Equity (x) |
2.7 |
2.7 |
2.6 |
2.6 |
2.5 |
|
|
|
|
|
|
|
Interest cover (x) |
78.4 |
61.0 |
55.1 |
53.9 |
54.1 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
- |
- |
|
Tax rate |
30.6% |
31.5% |
28 5% |
28.5% |
28.5% |
Payables |
3,738 |
3,655 |
3,594 |
3,583 |
3,585 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
3.4% |
2 2% |
2.1% |
1 9% |
2.7% |
Current liabilities |
3,738 |
3,655 |
3,594 |
3,583 |
3,585 |
|
EBITDA y/y Growth |
3.8% |
3.8% |
(6.8%) |
(1 9%) |
1.0% |
Long-term debt |
|
|
|
- |
- |
|
EPS y/y Growth |
(6.8%) |
1.8% |
(4 2%) |
(2 5%) |
0.8% |
Other long term liabilities |
1,010 |
815 |
815 |
815 |
815 |
|
|
|
|
|
|
|
Total liabilities |
4,748 |
4,470 |
4,409 |
4,398 |
4,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
3,077 |
2,957 |
3,070 |
3,158 |
3,173 |
|
P/E (x) |
10.4 |
10 2 |
10.7 |
11.0 |
10.9 |
Minority interests |
475 |
467 |
482 |
496 |
510 |
|
FCFE Yield |
11.0% |
10.1% |
7.9% |
8 5% |
8.8% |
Total liabilities & equity |
8,300 |
7,894 |
7,962 |
8,053 |
8,083 |
|
EV/EBITDA (x) |
6.8 |
6 5 |
7.0 |
7.2 |
6.6 |
|
|
|
|
|
|
|
Dividend Yield |
8.1% |
8.1% |
7.8% |
9.1% |
9.2% |
Net debt/(cash) |
- |
- |
- |
- |
- |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
69
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Neutral
Company Data
Price (€) |
7.58 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
8.30 |
Price Target End Date |
31-Dec-19 |
52-week Range (€) |
13.25-7.49 |
Market Cap (€ bn) |
1.61 |
Shares O/S (mn) |
212 |
TF1: DCF
WACC |
9.2% |
NPV to 2027E |
933 |
Terminal cashflow (normalised) |
162 |
LT growth rate |
0.5% |
Terminal Value |
1,867 |
Discounted Terminal Value |
774 |
Enterprise Value |
1,708 |
Associates |
0 |
Less: minorities |
-45 |
Net (debt)/cash end Dec 18E |
76 |
Equity Value |
1,739 |
Shares in Issue (m) |
210 |
Fair Value per share (€) |
€ 8.3 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
TF1
TF1 (TFFP.PA;TFI FP)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
0.76 |
0.61 |
0.72 |
0.68 |
Revenue FY (€ mn) |
2,125 |
2,249 |
2,318 |
2,296 |
EBIT FY (€ mn) |
185 |
187 |
214 |
202 |
DPS (Net) FY (€) |
0.35 |
0.33 |
0.39 |
0.37 |
Dividend Yield FY |
4.6% |
4.4% |
5.1% |
4.8% |
EBIT Margin FY |
8.7% |
8.3% |
9.2% |
8.8% |
Adjusted EBITDA FY (€ |
359 |
407 |
277 |
265 |
mn) |
|
|
|
|
Adjusted Diluted NP FY (€ |
159 |
128 |
149 |
140 |
mn) |
|
|
|
|
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks TF1 (Neutral; Price Target: €8.30)
Forecast Changes
We have reduced our NAR estimate for 2019 /20 from 0% / +1% to -1.5% / 0% to reflect our more cautious view on French TV advertising outlook. As a result our 2019 / 20 EPS decrease by -6% / -15% given the company high operational gearing.
Investment Thesis
We believe TF1’s valuation is unjustified given c10% EPS growth (2018E-21E CAGR), the future benefits from the Belgium ad window, French tax reform in 2020 and the upside for recent distribution deals with telco providers and accretive M&A / cash returns. With limited upside to our Price Target, we remain Neutral as we see European FTA broadcaster performance limited by macro factors and lack of catalysts for TF1.
Valuation
Our Dec-19 DCF-based PT (WACC of 9.2%, terminal growth of 0.5% vs. 1.5% prev.) remains decreases from €11.5 to €8.3 as a result of the decrease in our estimates.
Risks to Rating and Price Target
The following risks that could prevent the stock from achieving our target price and rating include: 1) Better / worse advertising revenues; 2) lower / higher-than-expected operating costs; 3) value-enhancing / diluting acquisitions; 4) unexpected gain/loss of audience share.
70